Reversible dopamine transporter reduction in drug-induced parkinsonism

Authors


  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Informed consent may be found in the online version of this article.

Correspondence to: Dr. Roberto Cilia, Parkinson Institute, Istituti Clinici di Perfezionamento, via Bignami 1, 20126 Milano, Italia; roberto.cilia@gmail.com

Ancillary